Evidence map›Paper›PMID 29042643›Full record

ArticleScientific reports2017

Measuring the Poisson's Ratio of Fibronectin Using Engineered Nanofibers.

John M Szymanski, Kairui Zhang, Adam W Feinberg

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Transfer of assembled collagen fibrils to flexible substrates for mechanically tunable contact guidance cues.Integrative biology : quantitative biosciences from nano to macro · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

John M SzymanskiDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA, 15213, USA.
Kairui ZhangDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA, 15213, USA.
Adam W FeinbergDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA, 15213, USA. feinberg@andrew.cmu.edu.ORCID 0000-0003-3338-5456
Carnegie Mellon University · US

Funding

Training in Biomechanics in Regenerative MedicineT32EB003392 · NIBIB · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WOO, SAVIO L-Y. · 2005 to 2020
$4.0M
Human Myocardium Engineered Using Developmentally-Inspired Protein ScaffoldsDP2HL117750 · NHLBI · CARNEGIE-MELLON UNIVERSITY · PI FEINBERG, ADAM WALTER · 2012 to 2012
$2.2M
NHLBI NIH HHS DP2 HL117750NIBIB NIH HHS T32 EB003392
6 · The paper itself

Abstract

The extracellular matrix (ECM) is a fibrillar protein-based network, the physical and chemical properties of which can influence a multitude of cellular processes. Despite having an important role in cell and tissue signaling, a complete chemo-mechanical characterization of ECM proteins such as fibronectin (FN) is lacking. In this study, we engineered monodisperse FN nanofibers using a surface-initiated assembly technique in order to provide new insight into the elastic behavior of this material over large deformations. FN nanofibers were patterned on surfaces in a pre-stressed state and when released from the surface underwent rapid contraction. We found that the FN nanofibers underwent 3.3-fold and 9-fold changes in length and width, respectively, and that the nanofiber volume was conserved. Volume was also conserved following uniaxial extension of the FN nanofibers of ~2-fold relative to the patterned state. This data suggests that the FN networks we engineered formed an incompressible material with a Poisson's ratio of ~0.5. While the Poisson's ratio of cells and other biological materials are widely estimated as 0.5, our experimental results demonstrate that for FN networks this is a reasonable approximation.

Indexed as

Compressive StrengthFibronectinsNanofibersFibronectins

Identifiers

PMID29042643
PMCPMC5645409
OpenAlexW2764188000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.